Case number 1:22-cv-01387
ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 28, 2024 | 83 | NOTICE OF SERVICE of Plaintiff Acadia Pharmaceuticals Inc.'s Reply Expert Report of Pamela A. Smith, Ph.D. Regarding Msn's Infringement of U.S. Patent No. 11,452,721 filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 06/28/2024) (2) |
| Jun 28, 2024 | 82 | NOTICE OF SERVICE of Plaintiff Acadia Pharmaceuticals, Inc.'s Reply Expert Report of Pamela A. Smith, Ph.D. Regarding Aurobindo Infringement of U.S. Patent No. 11,452,721 filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 06/28/2024) (2) |
| Jun 10, 2024 | 81 | NOTICE OF SERVICE of Plaintiff's Rebuttal Report of Pamela A. Smith, Ph.D. and Opening Report of Sean D. Sheridan, Ph.D. filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 06/10/2024) (2) |
| Jun 7, 2024 | 80 | NOTICE OF SERVICE of Aurobindo Defendants' Rebuttal Expert Report of R. Christian Moreton, Ph.D. on Noninfringement filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 06/07/2024) (2) |
| May 31, 2024 | 79 | NOTICE requesting Clerk to remove Patrick Lockwood as co-counsel. Reason for request: No longer with Saul Ewing LLP. (Streifthau-Livizos, Michelle) (Entered: 05/31/2024) (1) |
| Apr 18, 2024 | 78 | NOTICE of Defendants' Final Joint Initial Invalidity Contentions Regarding U.S. Patent No. 11,452,721 by MSN Laboratories Private Ltd. (Green, James) (Entered: 04/18/2024) (2) |
| Apr 4, 2024 | 77 | NOTICE OF SERVICE of Plaintiff's Final Infringement Contentions filed upon MSN filed by ACADIA Pharmaceuticals Inc..(Taylor, James) (Entered: 04/04/2024) (2) |
| Apr 4, 2024 | 76 | NOTICE OF SERVICE of Plaintiff's Final Infringement Contentions served upon Aurobindo filed by ACADIA Pharmaceuticals Inc..(Taylor, James) (Entered: 04/04/2024) (2) |
| Mar 28, 2024 | 75 | Joint STATUS REPORT by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) (Entered: 03/28/2024) (3) |
| Mar 21, 2024 | 74 | NOTICE OF SERVICE of Plaintiff's Supplemental Objections and Responses to Aurobindo's First Set of Interrogatories (Nos. 1, 4 and 7) filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 03/21/2024) (2) |
| Mar 21, 2024 | 73 | NOTICE OF SERVICE of Plaintiff's Supplemental Objections and Responses to Defendant MSN's First Set of Interrogatories Nos. 1 and 7 filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 03/21/2024) (2) |
| Mar 19, 2024 | 72 | NOTICE OF SERVICE of Plaintiff's Objections to 30(b)(6) Deposition Notices filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 03/19/2024) (2) |
| Mar 15, 2024 | 71 | MOTION for Pro Hac Vice Appearance of Attorney Michael Baldwin - filed by MSN Laboratories Private Ltd.. (Green, James) (Entered: 03/15/2024) (2) |
| Mar 15, 2024 | 70 | Pro Hac Vice Fee - Credit Card Payment received for Michael Baldwin. ( Payment of $ 50, receipt number ADEDC-4362559).(Green, James) (Entered: 03/15/2024) (0) |
| Mar 13, 2024 | 69 | NOTICE OF SERVICE of Plaintiff's Supplemental Objections and Responses to Defendant MSN's First Set of Interrogatories (No.7) filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 03/13/2024) (2) |
| Mar 12, 2024 | 68 | NOTICE OF SERVICE of Defendants' Joint Notice Of Rule 30(b)(6) Deposition Of Plaintiff filed by MSN Laboratories Private Ltd..(Green, James) (Entered: 03/12/2024) (2) |
| Mar 11, 2024 | 67 | NOTICE OF SERVICE of Supplemental Objections and Responses to Defendant Aurobindos First Set of Interrogatories (No. 7) filed by ACADIA Pharmaceuticals Inc..(Taylor, James) (Entered: 03/11/2024) (2) |
| Feb 23, 2024 | 66 | NOTICE OF SERVICE of Plaintiff's Supplemental Objections and Responses to Defendant Aurobindo's First Set of Interrogatories (No. 5) filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 02/23/2024) (2) |
| Feb 23, 2024 | 65 | NOTICE OF SERVICE of Plaintiff's Supplemental Objections and Responses to Defendant MSN's First Set of Interrogatories No. 5) filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 02/23/2024) (2) |
| Feb 16, 2024 | 64 | NOTICE OF SERVICE of Defendants' First Supplemental And Amended Joint Initial Invalidity Contentions Regarding U.S. Patent No. 11,452,721 filed by MSN Laboratories Private Ltd..(Green, James) (Entered: 02/16/2024) (1) |
| Feb 15, 2024 | 63 | NOTICE OF SERVICE of Plaintiff's Answers to Aurobindo's Interrogatories Nos. 1-8 filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 02/15/2024) (2) |
| Feb 14, 2024 | 62 | NOTICE OF SERVICE of Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.'s Responses and Objections to Plaintiff's First Set of Interrogatories (Nos. 1-10) filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 02/14/2024) (2) |
| Feb 14, 2024 | 61 | NOTICE OF SERVICE of Defendants MSN Laboratories Private Ltd. and MSN Pharmaceuticals, Inc.s Objections And Responses To Plaintiffs First Set Of Interrogatories (Nos. 1-10) filed by MSN Laboratories Private Ltd..(Green, James) (Entered: 02/14/2024) (2) |
| Feb 7, 2024 | 60 | SO ORDERED, re 59 STIPULATION to Amend Scheduling Order -- Fact Discovery completed by 3/21/2024. Status Report due by 3/28/2024. A 3-day Bench Trial is set for 12/3/2024 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. A Final Pretrial Conference is set for 11/26/2024 at 01:00 PM in Courtroom 6B before Judge Gregory B. Williams. Signed by Judge Gregory B. Williams on 2/7/24. (ntl) (Entered: 02/07/2024) (2) |
| Feb 6, 2024 | 59 | Joint STIPULATION to Amend Scheduling Order re 16 Scheduling Order,, by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) (Entered: 02/06/2024) (2) |
| Jan 10, 2024 | 58 | NOTICE OF SERVICE of Plaintiff's First Set of Interrogatories (Nos. 1-10) filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 01/10/2024) (2) |
| Jan 9, 2024 | 57 | NOTICE OF SERVICE of Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.'s First Set of Interrogatories to Plaintiff (Nos. 1-8) filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 01/09/2024) (2) |
| Jan 8, 2024 | 56 | NOTICE requesting Clerk to remove Rebecca A. Hilgar as co-counsel. Reason for request: no longer with the firm. (Streifthau-Livizos, Michelle) (Entered: 01/08/2024) (1) |
| Jan 8, 2024 | 55 | Pro Hac Vice Fee - Credit Card Payment received for Peter Conway. ( Payment of $ 50, receipt number ADEDC-4308838).(Streifthau-Livizos, Michelle) (Entered: 01/08/2024) (0) |
| Jan 8, 2024 | 54 | MOTION for Pro Hac Vice Appearance of Attorney Peter E. Conway - filed by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) (Entered: 01/08/2024) (3) |
| Jan 2, 2024 | 53 | MOTION for Pro Hac Vice Appearance of Attorney Julie Vernon - filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc.. (Green, James) (Entered: 01/02/2024) (2) |
| Jan 2, 2024 | 52 | MOTION for Pro Hac Vice Appearance of Attorney Bradford C. Frese - filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc.. (Green, James) (Entered: 01/02/2024) (2) |
| Jan 2, 2024 | 51 | MOTION for Pro Hac Vice Appearance of Attorney Janine A. Carlan - filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc.. (Green, James) (Entered: 01/02/2024) (2) |
| Jan 2, 2024 | 50 | Pro Hac Vice Fee - Credit Card Payment received for Julie Vernon. ( Payment of $ 50, receipt number ADEDC-4304501).(Green, James) (Entered: 01/02/2024) (0) |
| Jan 2, 2024 | 49 | Pro Hac Vice Fee - Credit Card Payment received for Bradford C. Frese. ( Payment of $ 50, receipt number ADEDC-4304500).(Green, James) (Entered: 01/02/2024) (0) |
| Jan 2, 2024 | 48 | Pro Hac Vice Fee - Credit Card Payment received for Janine A. Carlan. ( Payment of $ 50, receipt number ADEDC-4304498).(Green, James) (Entered: 01/02/2024) (0) |
| Jan 2, 2024 | 47 | MOTION for Pro Hac Vice Appearance of Attorney Richard J. Berman - filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc.. (Green, James) (Entered: 01/02/2024) (2) |
| Jan 2, 2024 | 46 | Pro Hac Vice Fee - Credit Card Payment received for Richard J. Berman. ( Payment of $ 50, receipt number ADEDC-4304470).(Green, James) (Entered: 01/02/2024) (0) |
| Dec 29, 2023 | 45 | NOTICE of Withdrawal of Appearance of Shashank Upadhye, Yixin Tang, and Brent Batzer as counsel for Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc. by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc. (Green, James) (Entered: 12/29/2023) (3) |
| Dec 13, 2023 | 44 | ORDER re 43 Memorandum Opinion regarding claim construction. The Markman hearing scheduled for 12/19/23 is CANCELLED. Signed by Judge Gregory B. Williams on 12/13/23. (ntl) (Entered: 12/13/2023) (2) |
| Dec 13, 2023 | 43 | MEMORANDUM OPINION re claim construction. Signed by Judge Gregory B. Williams on 12/13/23. (ntl) (Entered: 12/13/2023) (12) |
| Dec 6, 2023 | 42 | MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 12/06/2023) (2) |
| Nov 28, 2023 | 41 | NOTICE to Take Deposition of Christian Moreton, Ph.D. on December 4, 2023 filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 11/28/2023) (3) |
| Nov 27, 2023 | 40 | NOTICE to Take Deposition of Christian Schoneich, PhD on December 8, 2023 @ 8:30 a.m. CST filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc..(Green, James) (Entered: 11/27/2023) (2) |
| Nov 21, 2023 | 39 | JOINT CLAIM CONSTRUCTION BRIEF filed by ACADIA Pharmaceuticals Inc.. (Attachments: # 1 Appendix Joint Appendix with Exhibits 1-14)(Streifthau-Livizos, Michelle) (Additional attachment(s) added on 12/4/2023: # 2 Exhibit Exhibit 1 of Exhibit 14, # 3 Exhibit Exhibit 2 of Exhibit 14, # 4 Exhibit Exhibit 3 of Exhibit 14, # 5 Exhibit Exhibit 4 of Exhibit 14) (ntl). (Entered: 11/21/2023) (0) |
| Nov 16, 2023 | 38 | NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief and Second Declaration of R. Christian Moreton, Ph.D. filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 11/16/2023) (2) |
| Nov 7, 2023 | 37 | NOTICE of Joint Technology Tutorial by ACADIA Pharmaceuticals Inc. (Streifthau-Livizos, Michelle) (Entered: 11/07/2023) (19) |
| Nov 1, 2023 | 36 | STIPULATION TO EXTEND TIME for Defendants to Serve Claim Construction Sur-Reply Brief to November 16, 2023 - filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc.. (Green, James) (Entered: 11/01/2023) (2) |
| Oct 30, 2023 | 35 | NOTICE OF SERVICE of Acadia Pharmaceuticals Inc.'s Objections and Responses to Defendant's First Set of Requests for Production of Documents and Things (1-66) and Interrogatories (1-8) filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 10/30/2023) (3) |
| Oct 25, 2023 | 34 | NOTICE OF SERVICE of Plaintiff's Reply Claim Construction Brief and Declaration of Christian Schoneich, Ph.D. in Support of Plaintiff's Reply Claim Construction Brief filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 10/25/2023) (2) |
| Oct 5, 2023 | 33 | ORAL ORDER: IT IS HEREBY ORDERED that the parties are granted leave for each side to present live testimony from one expert witness during the Markman hearing scheduled for December 19, 2023, at 1:00 p.m., if they so choose. By no later than November 3, 2023, Plaintiff shall inform Defendants in writing whether Plaintiff will be presenting the live testimony of an expert witness during the Markman hearing and, if so, the identity of the witness. Likewise, by no later than November 17, 2023, Defendants shall inform Plaintiff in writing whether Defendants will be presenting the live testimony of an expert witness during the Markman hearing and, if so, the identity of the witness. Both parties shall make any such expert witnesses who are identified to testify during the Markman hearing available for deposition on a mutually agreeable date and time between November 20, 2023 and December 12, 2023. The Court has allocated three (3) hours for this hearing, with each side being allocated ninety (90) minutes for its presentation inclusive of any live witness testimony. ORDERED by Judge Gregory B. Williams on 10/5/23. (ntl) (Entered: 10/05/2023) (0) |
| Oct 3, 2023 | 32 | Letter to The Honorable Gregory B. Williams from Michelle C. Streifthau-Livizos regarding Markman Hearing. (Streifthau-Livizos, Michelle) (Entered: 10/03/2023) (2) |
| Sep 28, 2023 | 31 | NOTICE OF SERVICE of Defendants' First set of Interogatories to Plaintiff (Nos. 1-8) and Defendants' First Set of Requests to Plaitiff for the Production of Documents and Things (Nos. 1-66) filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc..(Green, James) (Entered: 09/28/2023) (1) |
| Aug 22, 2023 | 30 | Joint STIPULATION TO EXTEND TIME submission of Joint Technology Tutorial to 11/7/2023 - filed by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) (Entered: 08/22/2023) (2) |
| Aug 15, 2023 | 29 | CLAIM Construction Chart by ACADIA Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Exhibit X)(Lockwood, Patrick) (Entered: 08/15/2023) (0) |
| Aug 11, 2023 | 28 | NOTICE of Appearance by Patrick Lockwood on behalf of ACADIA Pharmaceuticals Inc. (Lockwood, Patrick) (Entered: 08/11/2023) (1) |
| Aug 8, 2023 | 27 | NOTICE OF SERVICE of Plaintiff's Proposed Claim Constructions in Response to Defendants' Proposed Terms for Construction filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 08/08/2023) (2) |
| Jul 27, 2023 | 26 | NOTICE OF SERVICE of Defendants Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., MSN Laboratories Private Ltd. and MSN Pharmaceuticals, Inc.'s Proposed Terms for Claim Construction filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 07/27/2023) (2) |
| Jul 27, 2023 | 25 | NOTICE OF SERVICE of Plaintiff Acadia's Proposed Terms for Construction filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 07/27/2023) (2) |
| Jul 13, 2023 | 24 | NOTICE OF SERVICE of Defendants Joint Initial Invalidity Contentions Regarding U.S. Patent No. 11,452,721 filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc..(Green, James) (Entered: 07/13/2023) (1) |
| Jun 7, 2023 | 23 | NOTICE OF SERVICE of Plaintiff's Paragraph 4(a) Disclosures Identifying the Asserted Patent and Accused Products filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 06/07/2023) (2) |
| Jun 2, 2023 | 21 | NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions to Aurobindo Pharma Limited filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 06/02/2023) (2) |
| Jun 2, 2023 | 22 | NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions to MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc. filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 06/02/2023) (2) |
| May 31, 2023 | 20 | Joint STIPULATION Protective Order by ACADIA Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2-4)(Streifthau-Livizos, Michelle) (Entered: 05/31/2023) (Exhibit 2-4) (7) |
| May 31, 2023 | 20 | Joint STIPULATION Protective Order by ACADIA Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2-4)(Streifthau-Livizos, Michelle) (Entered: 05/31/2023) (Exhibit 1) (30) |
| May 31, 2023 | 20 | Joint STIPULATION Protective Order by ACADIA Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2-4)(Streifthau-Livizos, Michelle) (Entered: 05/31/2023) (Main Document) (2) |
| May 25, 2023 | 19 | NOTICE OF SERVICE of Initial rule 26(a)(1) disclosures and ESI disclosures regarding custodians filed by ACADIA Pharmaceuticals Inc..(Streifthau-Livizos, Michelle) (Entered: 05/25/2023) (2) |
| May 25, 2023 | 18 | NOTICE OF SERVICE of MSNs Initial Disclosures Pursuant to Rule 26(a)(1) and Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc..(Green, Jared) (Entered: 05/25/2023) (1) |
| May 25, 2023 | 17 | NOTICE OF SERVICE of (1) Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.'s Initial Disclosures Pursuant to F.R.C.P. 26(a)(1); and (2) Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 05/25/2023) (2) |
| May 19, 2023 | 16 | SCHEDULING ORDER: Fact Discovery completed by 2/8/2024. Status Report due by 2/22/2024. Joint Claim Construction Brief due by 11/21/2023. A Markman Hearing is set for 12/19/2023 at 01:00 PM in Courtroom 6B before Judge Gregory B. Williams. A Final Pretrial Conference is set for 11/14/2024 at 02:00 PM in Courtroom 6B before Judge Gregory B. Williams. A 3-day Bench Trial is set for 12/2/2024 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. Signed by Judge Gregory B. Williams on 5/19/23. (ntl) (Entered: 05/19/2023) (13) |
| May 17, 2023 | 15 | Joint STIPULATION Case Consolidation by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) (Entered: 05/17/2023) (17) |
| Jan 2, 2023 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 01/02/2023) (2) |
| Jan 2, 2023 | 13 | MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 01/02/2023) (2) |
| Jan 2, 2023 | 12 | NOTICE OF SERVICE of Aurobindo's Production of Core Technical Documents Pursuant to Paragraph 4(b) of the Delaware Default Standard for Discovery and Pursuant to the Standing Order Regarding Hatch-Waxman Cases in Which Infringement is Alleged filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 01/02/2023) (2) |
| Jan 2, 2023 | 11 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 01/02/2023) (2) |
| Jan 2, 2023 | 10 | ANSWER to 1 Complaint, by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 01/02/2023) (15) |
| Dec 19, 2022 | 9 | NOTICE requesting Clerk to remove Aubrey J. Morin as co-counsel. Reason for request: No longer with the firm of Saul Ewing LLP. (Streifthau-Livizos, Michelle) (Entered: 12/19/2022) (1) |
| Dec 2, 2022 | 8 | MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Scott F. Peachman, Rebecca A. Hilgar and Felix A. Eyzaguirre - filed by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) (Entered: 12/02/2022) (7) |
| Nov 3, 2022 | 7 | WAIVER OF SERVICE returned executed by ACADIA Pharmaceuticals Inc.: For Aurobindo Pharma USA, Inc. waiver sent on 11/3/2022, answer due 1/3/2023. (Streifthau-Livizos, Michelle) (Entered: 11/03/2022) (1) |
| Nov 3, 2022 | 6 | WAIVER OF SERVICE returned executed by ACADIA Pharmaceuticals Inc.: For Aurobindo Pharma Limited waiver sent on 11/3/2022, answer due 1/3/2023. (Streifthau-Livizos, Michelle) (Entered: 11/03/2022) (1) |
| Oct 24, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) (Entered: 10/24/2022) (2) |
| Oct 21, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,452,271. (mkr) (Entered: 10/24/2022) (1) |
| Oct 21, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: See Attached. (mkr) (Entered: 10/24/2022) (2) |
| Oct 21, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 10/24/2022) (3) |
| Oct 21, 2022 | 1 | Complaint* (1) |
